The cancer-associated meprin β variant G32R provides an additional activation site and promotes cancer cell invasion

Area of Science:

• Biochemistry
• Molecular Biology
• Cancer Research

Background:

• Meprin β is an extracellular metalloprotease, typically membrane-bound.
• It can be shed from the cell surface by ADAM10 and ADAM17 sheddases.
• Cell surface activation prevents shedding, stabilizing meprin β activity.

Purpose of the Study:

• To investigate the functional impact of the meprin β G32R variant identified in endometrium cancer.
• To determine the mechanisms underlying the altered activity and shedding of the G32R variant.
• To assess the effects of the G32R variant on cancer cell behavior.

Main Methods:

• Enzyme activity assays using peptide substrates and IL-6 receptor.
• Analysis of meprin β activation and shedding pathways.
• In vitro assessment of cell proliferation, invasion, and tumor spheroid outgrowth.

Main Results:

• The G32R variant exhibits higher proteolytic activity than wild-type meprin β.
• The G32R substitution creates an additional furin cleavage site, reducing ADAM17-mediated shedding.
• Increased cell surface activity of G32R meprin β decreased proliferation but enhanced invasion.

Conclusions:

• The G32R variant represents a functionally distinct form of meprin β with implications for endometrium cancer.
• Altered activation and shedding mechanisms contribute to the variant's pro-invasive phenotype.
• Meprin β G32R's impact on cell proliferation and invasion warrants further investigation in cancer progression.